Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients
Open Access
- 1 April 2003
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Liver Transplantation
- Vol. 9 (4), 383-388
- https://doi.org/10.1053/jlts.2003.50022
Abstract
The aim of this study is to study mycophenolic acid (MPA) pharmacokinetics in stable pediatric liver transplant recipients and determine which times best represent the area under the concentration versus time curve (AUC) of MPA plasma concentrations. MPA pharmacokinetic profiles were determined in 21 liver transplant recipients (age, 2 to 15 years; 12 boys) administered mycophenolate mofetil (MMF) for at least 6 months. Ten patients were coadministered cyclosporine A (CsA), and 11 patients were coadministered tacrolimus (Tac). Plasma MPA levels were analyzed by enzyme‐multiplied immunoassay technique in blood samples at 0, 0.33, 0.67, 1.25, 2, 3.5, 5, and 7 hours after MMF administration. The AUC of plasma concentrations to 7 hours (AUC0‐7) was calculated using the linear trapezoidal rule. MPA plasma trough concentration (C0), maximal concentration, and AUC0‐7 values ranged 9‐ to 14‐fold at a median of 1.81 mg/L (range, 0.4 to 3.7 mg/L), 10.5 mg/L (range, 2.8 to 40.0 mg/L), and 30.2 mg/L.hr (range, 9.3 to 80.3 mg/L.hr), respectively. AUC0‐7 correlated significantly with MMF dose (r = 0.552; P = .010) and C0 (r = 0.844; P < .001). Median AUC0‐7 (29.6 v 31.4 mg/L.hr; P = .918) was similar in children comedicated with CsA or Tac. Median MMF dose was greater in the CsA group (500 v 250 mg; P = .006). Consequently, median AUC0‐7 was significantly lower in the CsA group when equalized for dose and body weight (2.02 v 3.85 μg/L.hr per mg of MMF dose per kg of weight; P = .002). Variations of MPA pharmacokinetics in pediatric liver transplant recipients suggest that monitoring MPA plasma levels is required. C0 correlates closely with AUC. Comedication with CsA increased MMF dosage requirements compared with children on Tac therapy.Keywords
This publication has 22 references indexed in Scilit:
- Mycophenolate Mofetil Pharmacokinetics in Transplant Patients Receiving Cyclosporine or Tacrolimus in Combination TherapyBasic & Clinical Pharmacology & Toxicology, 2000
- Pharmacokinetics and pharmacodynamics of mycophenolic acid in stable renal transplant recipients treated with low doses of mycophenolate mofetilTransplant International, 2000
- EFFECT OF CYCLOSPORINE ON MYCOPHENOLIC ACID TROUGH LEVELS IN KIDNEY TRANSPLANT RECIPIENTS1Transplantation, 1999
- Area Under the Plasma Concentration–Time Curve for Total, But Not for Free, Mycophenolic Acid Increases in the Stable Phase After Renal Transplantation: A Longitudinal Study in Pediatric PatientsTherapeutic Drug Monitoring, 1999
- Drug Interaction Between Mycophenolate Mofetil and Tacrolimus Detectable Within Therapeutic Mycophenolic Acid Monitoring in Renal Transplant PatientsTherapeutic Drug Monitoring, 1999
- A RANDOMIZED DOUBLE-BLIND, MULTICENTER PLASMA CONCENTRATION CONTROLLED STUDY OF THE SAFETY AND EFFICACY OF ORAL MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION AFTER KIDNEY TRANSPLANTATION1Transplantation, 1999
- Mycophenolate mofetil, microemulsion cyclosporine, and prednisone as primary immunosuppression for pediatric liver transplant recipientsLiver Transplantation and Surgery, 1999
- Clinical Pharmacokinetics of Mycophenolate MofetilClinical Pharmacokinetics, 1998
- MYCOPHENOLATE MOFETIL FOR THE PREVENTION OF ACUTE REJECTION IN PRIMARY CADAVERIC RENAL ALLOGRAFT RECIPIENTSTransplantation, 1995
- Immunosuppressive Activity of Mycophenolate MofetilAnnals of the New York Academy of Sciences, 1993